The Efficiency of a New Sperm-Wash Device for Intrauterine Insemination in Couples With Infertility
Launched by CHUNG SHAN MEDICAL UNIVERSITY · May 1, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new device designed to wash sperm for couples experiencing infertility. The goal is to see if this new method can help improve pregnancy rates during intrauterine insemination (IUI), a common fertility treatment. Traditional sperm washing methods can cause damage to the sperm, which might lower the chances of getting pregnant. The researchers believe that the new device may help protect the sperm and lead to better outcomes for couples trying to conceive.
To participate in this trial, men aged 25 to 50 who are part of a couple diagnosed with infertility may be eligible. They should be undergoing IUI treatment and have a certain level of healthy sperm. Participants will be randomly assigned to either use the new device or the traditional method, and the main focus will be on whether they achieve pregnancy. It's important to note that couples with certain severe infertility issues or who have participated in another clinical trial recently may not qualify. This study aims to provide valuable information that could improve fertility treatments in the future.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Males aged between 25 to 50 years.
- • Part of a couple diagnosed with infertility.
- • Undergoing intrauterine insemination (IUI) treatment.
- • Sperm concentration \>15 million/mL, progressive motility \>32%, and total motile sperm count \>40 million after wash.
- • Willingness of both partners to participate and provide informed consent.
- Exclusion Criteria:
- • Known female infertility factors requiring assisted reproductive technologies beyond IUI.
- • Severe male factor infertility (e.g., oligoasthenoteratozoospermia).
- • Use of donor sperm or oocyte.
- • Chronic illness or medications affecting sperm quality.
- • Prior participation in another clinical trial within the past 3 months.
About Chung Shan Medical University
Chung Shan Medical University is a distinguished academic institution dedicated to advancing medical education, research, and healthcare services. As a clinical trial sponsor, the university leverages its expertise in medical sciences and innovative research methodologies to conduct rigorous and ethically sound clinical studies. With a commitment to enhancing patient care and contributing to the global body of medical knowledge, Chung Shan Medical University collaborates with healthcare professionals and research institutions to explore new therapeutic interventions and improve clinical outcomes. Through its comprehensive approach to research, the university plays a pivotal role in fostering advancements in medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung, , Taiwan
Patients applied
Trial Officials
Tsung-Hsien Lee, M.D., Ph.D.
Principal Investigator
Chung Shan Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported